Sum. Medicamentos e Insumos para Cosam Pp25-23
La presente propuesta pública tiene como objetivo adquirir o contratar Medicamentos e Insumos para Centros Comunitarios de Salud Mental - COSAM del Servicio de Salud Antofagasta.
32 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 769-4652-SE25 | 08-07-2025 | Ascend Laboratories SpA | $2.426.886 |
| 769-4651-SE25 | 08-07-2025 | Laboratorios Andromaco S.A. | $614.611 |
| 769-4657-SE25 | 08-07-2025 | Ascend Laboratories SpA | $3.254.769 |
| 769-4655-SE25 | 08-07-2025 | Laboratorio Chile S.A. | $1.124.550 |
| 769-4654-SE25 | 07-07-2025 | Laboratorio Chile S.A. | $2.409.750 |
| 769-4653-SE25 | 07-07-2025 | Galenicum Health Chile SpA | $2.199.120 |
| 769-4641-SE25 | 02-07-2025 | Laboratorios Recalcine S.A. | $1.931.370 |
| 769-4640-SE25 | 02-07-2025 | Galenicum Health Chile SpA | $647.360 |
| 769-4614-SE25 | 26-06-2025 | Ascend Laboratories SpA | $1.053.864 |
| 769-4613-SE25 | 26-06-2025 | Galenicum Health Chile SpA | $1.929.585 |
| 769-4576-SE25 | 17-06-2025 | Johnson y Johnson de Chile S.A. | $1.482.597 |
| 769-4580-SE25 | 17-06-2025 | Novofarma Service S.A. | $2.998.800 |
| 769-4573-SE25 | 17-06-2025 | Laboratorios Andromaco S.A. | $512.176 |
| 769-4575-SE25 | 17-06-2025 | Galenicum Health Chile SpA | $3.661.535 |
| 769-4577-SE25 | 17-06-2025 | Laboratorio Chile S.A. | $2.788.170 |
| 769-4546-SE25 | 12-06-2025 | Ethon Pharmaceuticals Ltda. | $2.863.854 |
| 769-4492-SE25 | 26-05-2025 | Ascend Laboratories SpA | $2.606.100 |
| 769-4467-SE25 | 15-05-2025 | Ascend Laboratories SpA | $6.426.000 |
| 769-4468-SE25 | 15-05-2025 | Johnson y Johnson de Chile S.A. | $2.965.194 |
| 769-4442-SE25 | 06-05-2025 | Ascend Laboratories SpA | $2.078.335 |
| 769-4431-SE25 | 30-04-2025 | Laboratorio Chile S.A. | $2.342.277 |
| 769-4434-SE25 | 30-04-2025 | Johnson y Johnson de Chile S.A. | $1.482.597 |
| 769-4432-SE25 | 30-04-2025 | Galenicum Health Chile SpA | $3.665.200 |
| 769-4313-SE25 | 20-03-2025 | Guillermo Harding y Compania Limitada | $7.444.521 |
| 769-4315-SE25 | 20-03-2025 | Novofarma Service S.A. | $2.998.800 |
| 769-4311-SE25 | 20-03-2025 | Ethon Pharmaceuticals Ltda. | $2.386.545 |
| 769-4314-SE25 | 20-03-2025 | Ethon Pharmaceuticals Ltda. | $333.450 |
| 769-4266-SE25 | 11-03-2025 | Galenicum Health Chile SpA | $4.398.240 |
| 769-4269-SE25 | 11-03-2025 | Guillermo Harding y Compania Limitada | $7.444.521 |
| 769-4267-SE25 | 11-03-2025 | Laboratorio Chile S.A. | $2.034.900 |
| 769-4204-SE25 | 17-02-2025 | Johnson y Johnson de Chile S.A. | $2.223.896 |
| 769-30-SE25 | 27-01-2025 | Laboratorios Recalcine S.A. | $2.320.500 |
| 769-7-SE25 | 08-01-2025 | Ascend Laboratories SpA | $532.358 |
| 769-9-SE25 | 08-01-2025 | Johnson y Johnson de Chile S.A. | $1.482.597 |
| 769-1350-SE24 | 18-12-2024 | Galenicum Health Chile SpA | $2.199.120 |
| 769-1349-SE24 | 18-12-2024 | Novofarma Service S.A. | $1.999.200 |
| 769-1348-SE24 | 18-12-2024 | Ethon Pharmaceuticals Ltda. | $5.959.758 |
| 769-1257-SE24 | 21-11-2024 | Guillermo Harding y Compania Limitada | $10.621.214 |
| 769-1258-SE24 | 21-11-2024 | Galenicum Health Chile SpA | $2.344.300 |
| 769-1106-SE24 | 11-10-2024 | Guillermo Harding y Compania Limitada | $3.208.930 |
| 769-1108-SE24 | 11-10-2024 | Galenicum Health Chile SpA | $194.565 |
| 769-1104-SE24 | 10-10-2024 | Ascend Laboratories SpA | $1.042.440 |
| 769-1101-SE24 | 10-10-2024 | Johnson y Johnson de Chile S.A. | $2.223.896 |
| 769-1066-SE24 | 08-10-2024 | Ascend Laboratories SpA | $8.907.150 |
| 769-1070-SE24 | 08-10-2024 | Ascend Laboratories SpA | $1.756.440 |
| 769-982-SE24 | 09-09-2024 | Novofarma Service S.A. | $999.600 |
| 769-985-SE24 | 09-09-2024 | Ascend Laboratories SpA | $456.246 |
| 769-979-SE24 | 09-09-2024 | Ethon Pharmaceuticals Ltda. | $4.469.819 |
| 769-981-SE24 | 09-09-2024 | Galenicum Health Chile SpA | $5.497.800 |
| 769-983-SE24 | 09-09-2024 | Johnson y Johnson de Chile S.A. | $741.299 |
| 769-877-SE24 | 23-08-2024 | Ethon Pharmaceuticals Ltda. | $75.506 |
| 769-850-SE24 | 23-08-2024 | Guillermo Harding y Compania Limitada | $14.824.568 |
| 769-797-SE24 | 06-08-2024 | Galenicum Health Chile SpA | $897.855 |
| 769-799-SE24 | 06-08-2024 | Galenicum Health Chile SpA | $121.380 |
| 769-658-SE24 | 26-06-2024 | Galenicum Health Chile SpA | $492.303 |
| 769-659-SE24 | 26-06-2024 | Ascend Laboratories SpA | $228.123 |
| 769-634-SE24 | 25-06-2024 | Novofarma Service S.A. | $399.840 |
| 769-635-SE24 | 19-06-2024 | Johnson y Johnson de Chile S.A. | $7.413.046 |
| 769-636-SE24 | 19-06-2024 | Galenicum Health Chile SpA | $2.528.988 |
| 769-494-SE24 | 15-05-2024 | Laboratorios Recalcine S.A. | $1.160.250 |
| 769-495-SE24 | 15-05-2024 | Ethon Pharmaceuticals Ltda. | $6.236.433 |
| 769-475-SE24 | 07-05-2024 | Guillermo Harding y Compania Limitada | $5.294.489 |
| 769-476-SE24 | 07-05-2024 | Tecnika S.A. | $771.120 |
| 769-474-SE24 | 07-05-2024 | Novofarma Service S.A. | $399.840 |
| 769-139-SE24 | 22-02-2024 | Gadorpharma SpA | $2.152.710 |
| 769-1381-SE23 | 02-02-2024 | Laboratorios Andromaco S.A. | $5.484.643 |
| 769-1403-SE23 | 02-02-2024 | Ascend Laboratories SpA | $7.477.051 |
| 769-31-SE24 | 11-01-2024 | Ethon Pharmaceuticals Ltda. | $16.940.550 |
| 769-20-SE24 | 10-01-2024 | Laboratorio Chile S.A. | $3.498.695 |
| 769-21-SE24 | 10-01-2024 | Laboratorios Recalcine S.A. | $6.764.936 |
| 769-22-SE24 | 10-01-2024 | Guillermo Harding y Compania Limitada | $603.687 |
| 769-23-SE24 | 10-01-2024 | Winpharm SpA | $1.464.533 |
| 769-1130-SE23 | 30-10-2023 | Opko Chile S.A. | $1.523.200 |
| 769-1129-SE23 | 30-10-2023 | Laboratorios Recalcine S.A. | $1.547.000 |
| 769-1128-SE23 | 30-10-2023 | Valtek S.A. | $274.057 |
| 769-1115-SE23 | 30-10-2023 | Ethon Pharmaceuticals Ltda. | $12.104.799 |
| 769-1127-SE23 | 30-10-2023 | Laboratorio Chile S.A. | $3.065.559 |
| 769-1133-SE23 | 30-10-2023 | Guillermo Harding y Compania Limitada | $14.382.358 |
| 769-1132-SE23 | 30-10-2023 | Johnson y Johnson de Chile S.A. | $31.876.078 |
| 769-1131-SE23 | 30-10-2023 | Galenicum Health Chile SpA | $10.124.948 |
| 769-1125-SE23 | 30-10-2023 | Laboratorios Andromaco S.A. | $11.091.276 |
| 769-1068-SE23 | 13-10-2023 | Ethon Pharmaceuticals Ltda. | $12.104.918 |
| 769-1038-SE23 | 06-10-2023 | Opko Chile S.A. | $380.800 |
| 769-1039-SE23 | 06-10-2023 | Laboratorios Recalcine S.A. | $1.547.000 |
| 769-1035-SE23 | 06-10-2023 | Laboratorios Andromaco S.A. | $1.758.820 |
| 769-982-SE23 | 03-10-2023 | Laboratorios Recalcine S.A. | $464.100 |
| 769-978-SE23 | 03-10-2023 | Ethon Pharmaceuticals Ltda. | $3.280.533 |
| 769-976-SE23 | 03-10-2023 | Ascend Laboratories SpA | $1.187.620 |
| 769-979-SE23 | 03-10-2023 | Galenicum Health Chile SpA | $323.680 |
| 769-980-SE23 | 03-10-2023 | Laboratorio Chile S.A. | $2.027.760 |
| 769-981-SE23 | 03-10-2023 | Guillermo Harding y Compania Limitada | $2.446.343 |
| 769-900-SE23 | 07-09-2023 | Opko Chile S.A. | $361.760 |
| 769-901-SE23 | 07-09-2023 | Ethon Pharmaceuticals Ltda. | $3.182.060 |
| 769-619-SE23 | 04-09-2023 | Winpharm SpA | $428.400 |
| 769-620-SE23 | 04-09-2023 | Novofarma Service S.A. | $307.877 |
| 769-613-SE23 | 01-09-2023 | Guillermo Harding y Compania Limitada | $978.487 |
| 769-623-SE23 | 01-09-2023 | Galenicum Health Chile SpA | $971.040 |
| 769-621-SE23 | 01-09-2023 | Ascend Laboratories SpA | $5.982.249 |
| 769-855-SE23 | 30-08-2023 | Ethon Pharmaceuticals Ltda. | $1.642.200 |
| 769-780-SE23 | 10-08-2023 | Laboratorios Andromaco S.A. | $4.394.439 |
| 769-787-SE23 | 10-08-2023 | Laboratorio Chile S.A. | $3.462.019 |
| 769-779-SE23 | 10-08-2023 | Ethon Pharmaceuticals Ltda. | $6.912.872 |
| 769-773-SE23 | 09-08-2023 | Ethon Pharmaceuticals Ltda. | $83.895 |
| 769-776-SE23 | 09-08-2023 | Winpharm SpA | $416.500 |
Fuente original:ficha mercadopublico.cl
